Gmp Capital Inc (GMPXF) 4.0602 $GMPXF GMP Capital

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gmp Capital Inc (GMPXF) 4.0602 $GMPXF

GMP Capital announces election of directors
CNW Group - Fri Apr 29, 12:51PM CDT
GMP Capital Inc. (GMP) (TSX:GMP) today announced that the nominees listed in the Management Information Circular dated March 21, 2016, were elected as directors of GMP. The detailed results of the vote for the election of directors held at GMP's Annual Meeting of Common Shareholders (the Meeting) on Thursday, April 28, 2016, in Toronto, Ontario, are set out below.
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. reports first quarter 2016 results
CNW Group - Thu Apr 28, 5:00AM CDT
For further information about GMP Capital Inc., our results for first quarter 2016 and the meaning of certain references, this earnings release should be read in conjunction with our unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2016 (First Quarter 2016 Financial Statements), and our management's discussion and analysis for the three months ended March 31, 2016 (First Quarter 2016 MD&A), which can be accessed on our website at gmpcapital.com and on SEDAR at sedar.com. Unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been taken from our First Quarter 2016 Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS).
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. Announces Results of the Conversion Privilege of its Cumulative 5-Year Rate Reset Preferred Shares, Series B and Listing of Cumulative Floating Rate Preferred Shares, Series C
CNW Group - Wed Mar 16, 5:39PM CDT
GMP Capital Inc. (the Corporation) (TSX: GMP, GMP.PR.B) announced today that 1,034,747 of its outstanding 4,600,000 Cumulative 5-Year Rate Reset Preferred Shares, Series B of the Corporation (the Series B Shares) have been tendered for conversion on March 31, 2016, on a one-for-one basis, into Cumulative Floating Rate Preferred Shares, Series C of the Corporation (the Series C Shares). As a result, on March 31, 2016, the Corporation will have 3,565,253 Series B Shares and 1,034,747 Series C Shares issued and outstanding.
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. Announces Dividend Rates on Cumulative 5-Year Rate Reset Preferred Shares, Series B and Cumulative Floating Rate Preferred Shares, Series C
CNW Group - Wed Mar 02, 4:02PM CST
GMP Capital Inc. (the Corporation) (TSX: GMP, GMP.PR.B) announced today the applicable dividend rates for its Cumulative 5-Year Rate Reset Preferred Shares, Series B (the Series B Shares) and its Cumulative Floating Rate Preferred Shares, Series C (the Series C Shares), further to its press release dated February 23, 2016, announcing that it does not intend to exercise its right to redeem all or any part of the currently outstanding Series B Shares and, as a result of which, subject to certain conditions, the holders of the Series B Shares have the right to convert all or any part of their Series B Shares into Series C Shares on a one-for-one basis.
GMP.TO: 5.20 (-0.06)

Media Advisory - GMP Capital Inc. to Announce Fourth Quarter and Fiscal 2015 Results
CNW Group - Wed Feb 03, 11:56AM CST
GMP Capital Inc. (GMP) (TSX: GMP) will announce its fourth quarter and fiscal 2015 financial results and host an earnings conference call on Friday, March 11, 2016. Financial results are expected to be released at approximately 6:00 a.m. (ET).
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. Reports Third Quarter 2015 Results
CNW Group - Fri Nov 06, 5:00AM CST
For further information about GMP Capital Inc., our results for third quarter 2015 and the meaning of certain references, this earnings release should be read in conjunction with our unaudited interim condensed consolidated financial statements as at and for the three and nine months ended September 30, 2015 (Third Quarter 2015 Financial Statements), and our management's discussion and analysis for the three and nine months ended September 30, 2015 (Third Quarter 2015 MD&A), which can be accessed on our website at gmpcapital.com and on SEDAR at sedar.com. Unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been taken from our Third Quarter 2015 Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS).
GMP.TO: 5.20 (-0.06)

GMP Capital to Announce Third Quarter 2015 Results
CNW Group - Mon Oct 05, 10:55AM CDT
GMP Capital Inc. (GMP) (TSX: GMP) will release its third quarter 2015 financial results on Friday, November 6, 2015. Third quarter results are expected to be released at approximately 6:00 a.m. (ET).
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. Reports Second Quarter 2015 Results
CNW Group - Fri Aug 07, 5:00AM CDT
For further information about GMP Capital Inc., our results for second quarter 2015 and the meaning of certain references, this earnings release should be read in conjunction with our unaudited interim condensed consolidated financial statements as at and for the three and six months ended June 30, 2015 (Second Quarter 2015 Financial Statements), and our management's discussion and analysis for the three and six months ended June 30, 2015 (Second Quarter 2015 MD&A), which can be accessed on our website at gmpcapital.com and on SEDAR at sedar.com. Unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been taken from our Second Quarter 2015 Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS).
GMP.TO: 5.20 (-0.06)

Media Advisory - GMP Capital to Announce Second Quarter 2015 Results
CNW Group - Mon Jul 06, 1:51PM CDT
GMP Capital Inc. (GMP) (TSX: GMP) will release its second quarter 2015 financial results on Friday, August 7, 2015. Second quarter results are expected to be released at approximately 6:00 a.m. (EST).
GMP.TO: 5.20 (-0.06)

GMP Capital Inc., Richardson Financial Group Limited and Richardson GMP Limited announce Richardson GMP shareholder liquidity and investor agreement amendments
CNW Group - Tue May 05, 7:43AM CDT
GMP Capital Inc. (GMP) (TSX: GMP), Richardson Financial Group Limited (RFGL), a subsidiary of James Richardson & Sons, Limited (JRSL), and Richardson GMP Limited today jointly announced that they have entered into an agreement to formalize the amendments to the Richardson GMP Limited's (Richardson GMP) shareholders' agreement (Shareholders Agreement) regarding changes to the Richardson GMP shareholder liquidity mechanism (Richardson GMP Liquidity Mechanism) as previously announced on January 13, 2013. The material aspects of the original Richardson GMP Liquidity Mechanism are summarized in GMP's annual information form dated March 5, 2015. GMP and RFGL each own approximately 30% per cent of the issued and outstanding common shares of Richardson GMP, with the balance being held by Richardson GMP's investment advisory and management teams.
GMP.TO: 5.20 (-0.06)

Media Advisory - GMP Capital to announce first quarter 2015 results and hold annual and special meeting of common shareholders on April 30, 2015
CNW Group - Wed Apr 01, 11:27AM CDT
GMP Capital Inc. (GMP) will release its first quarter 2015 financial results and hold its annual and special meeting of common shareholders (Annual Meeting) on Thursday, April 30, 2015. First quarter results are expected to be released at approximately 6:00 a.m. (EST).
GMP.TO: 5.20 (-0.06)

GMP Capital Inc. Discloses Purchases in Own Shares Pursuant to its Normal Course Issuer Bid
CNW Group - Tue Dec 16, 2:35PM CST
GMP Capital Inc. (GMP) (TSX: GMP) today announced that for the period of November 1, 2014 to December 15, 2014, it purchased for cancellation 1,518,990 of its common shares through the facilities of the Toronto Stock Exchange and alternative trading systems pursuant to its normal course issuer bid announced on May 1, 2014 (NCIB). The volume-weighted average price per common share was $5.99.
GMP.TO: 5.20 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading